Essex Bio-Technology Limited (HKG:1061)
Hong Kong · Delayed Price · Currency is HKD 2.090
+0.075 (3.72%)
Oct 30, 2026, 4:08 PM HKT
Essex Bio-Technology Financials Overview
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,722 | 1,814 | 1,670 | 1,737 | 1,318 | 1,638 |
Revenue Growth | -5.06% | 8.62% | -3.87% | 31.82% | -19.54% | 67.43% |
Gross Profit Gross Profit Growth | 1,496 | 1,618 | 1,499 | 1,562 | 1,189 | 1,396 |
Operating Income Operating Income Growth | 343.76 | 416.78 | 354.79 | 351.57 | 301.97 | 393.82 |
Net Income Net Income Growth | 265.41 | 318.09 | 307.22 | 275.26 | 225.41 | 345.97 |
Earnings Per Share EPS Growth | 0.47 | 0.56 | 0.53 | 0.47 | 0.38 | 0.58 |
EPS Growth | -16.56% | 5.49% | 13.38% | 22.52% | -34.14% | 55.93% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Surgical Surgical Growth | 788.17 | 895.9 | 879.9 | 970.4 | 764.15 | 964.39 |
Ophthalmology Ophthalmology Growth | 784.89 | 835.03 | 771.49 | 755.03 | 553.56 | 673.27 |
Healthcare and Partner Services Healthcare and Partner Services Growth | 148.91 | 82.87 | 18.42 | 11.54 | - | - |
Total Total Growth | 1,722 | 1,814 | 1,670 | 1,737 | 1,318 | 1,638 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 807.73 | 784.14 | 560.74 | 515.03 | 543.49 | 671.35 |
Total Debt Total Debt Growth | 348.99 | 346.9 | 187.04 | 294.02 | 489.73 | 565.19 |
Net Cash (Debt) Net Cash Growth | 458.74 | 437.24 | 373.7 | 221 | 53.76 | 106.17 |
Net Cash Growth | 4.92% | 17.00% | 69.09% | 311.11% | -49.36% | 186.75% |
Net Cash Per Share Net Cash Per Share Growth | 0.81 | 0.77 | 0.64 | 0.37 | 0.09 | 0.18 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 282.52 | 306.32 | 368.47 | 339.21 | 382.79 | 409.16 |
Capital Expenditures CapEx Growth | -64.22 | -107.51 | -44.4 | -21.03 | -89.49 | -90.05 |
Free Cash Flow Free Cash Flow Growth | 218.29 | 198.81 | 324.07 | 318.17 | 293.29 | 319.12 |
Free Cash Flow Growth | 9.80% | -38.65% | 1.85% | 8.48% | -8.09% | 57.87% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 86.85% | 89.20% | 89.75% | 89.93% | 90.26% | 85.23% |
Operating Margin | 19.96% | 22.98% | 21.25% | 20.24% | 22.92% | 24.05% |
Pretax Margin | 20.85% | 22.86% | 22.49% | 19.92% | 19.76% | 24.09% |
Profit Margin | 15.41% | 17.54% | 18.40% | 15.85% | 17.11% | 21.13% |
FCF Margin | 12.68% | 10.96% | 19.41% | 18.32% | 22.26% | 19.49% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.140 | 0.140 | 0.120 | 0.090 | 0.065 | 0.095 |
Dividend Per Share Growth | -7.69% | 16.67% | 33.33% | 38.46% | -31.58% | 90.00% |
Dividend Yield | 6.70% | 3.71% | 4.08% | 3.62% | 1.55% | 1.92% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 4.46 | 6.72 | 5.43 | 5.13 | 10.65 | 8.23 |
Forward PE | 3.67 | 5.98 | 5.97 | 3.62 | 6.39 | 7.95 |
P/FCF Ratio | 5.41 | 10.75 | 5.15 | 4.44 | 8.19 | 8.93 |
PS Ratio | 0.69 | 1.18 | 1.00 | 0.81 | 1.82 | 1.74 |